Byline: Nora Dunne
-
Influencing Hospitals, Clinicians and Policymakers to Improve Patient Care
Karl Bilimoria, MD, director of the Northwestern Surgical Outcomes and Quality Improvement Center, discusses his team’s research to elevate the quality of care patients receive.
-
Reverse Engineering the Eye’s Retina
Gregory Schwartz, PhD, assistant professor of Ophthalmology and Physiology, and his lab map neural circuits in the retina that send visual information to the brain, work that could inform future treatments for blindness.
-
Examining Optimal Dosage for Heart Failure Drug
A clinical trial led by Northwestern Medicine scientist Mihai Gheorghiade, MD, opens the door for further investigation of a new drug to treat the more than one million patients in the United States hospitalized for heart failure every year.
-
Blocking Sodium Channel Helps Skin Heal
Blocking the sodium channel protein Nax decreased scarring and atopic dermatitis, an inflammatory skin disorder, by improving the skin’s barrier function in a new Northwestern Medicine study.
-
Renowned Economist Discusses Pathways to Universal Health
United Nations advisor Jeffrey Sachs, PhD, delivered the keynote address at Northwestern University’s Global Health Interdisciplinary Symposium Nov. 19.
-
Diet During Young Adulthood Linked to Later Cardiovascular Disease
People who ate more fruits and vegetables as young adults were less likely to develop coronary atherosclerosis 20 years later, according to a recent study co-authored by Northwestern Medicine investigator Philip Greenland, MD.
-
Faculty Receive NCI Outstanding Investigator Awards for Cancer Research
Marcus Peter, PhD, professor of Medicine in the Division of Hematology/Oncology, and Ali Shilatifard, PhD, chair of Biochemistry and Molecular Genetics, and Maciej Lesniak, MD, chair of Neurological Surgery, have each been awarded seven-year, $6.4 million grants from the National Cancer Institute.
-
Promising Strategy for Treating Rare Forms of Leukemia Discovered
Northwestern Medicine scientists identified a drug that stops the reproduction of tumor cells in models of primary myelofibrosis and acute myeloid leukemia, a finding that has led to new clinical studies in the Lurie Cancer Center.
-
Finding a New Cause for Cardiac Injury in Kidney Disease
A recent study co-authored by Northwestern Medicine scientists demonstrates the molecular mechanisms that may underlie left ventricular hypertrophy, a pattern of cardiac injury common in patients with chronic kidney disease.
-
How the Circadian Clock Controls Insulin and Blood Sugar Regulation in the Pancreas
Northwestern Medicine scientists pinpointed a master switch that orchestrates thousands of genetic pathways an internal body clock takes to dictate how and when our pancreas must produce insulin and control blood sugar.
